Genomic and phenotypic analysis of BRCA2mutated breast cancers reveals co-occurring changes linked to progression

被引：0
|
作者：
Olafur A Stefansson
Jon G Jonasson
Kristrun Olafsdottir
Hordur Bjarnason
Oskar Th Johannsson
Sigridur K Bodvarsdottir
Sigridur Valgeirsdottir
Jorunn E Eyfjord
机构：
[1] University of Iceland,Cancer Research Laboratory, Faculty of Medicine
[2] Landspitali University Hospital,Department of Pathology
[3] Landspitali University Hospital,Department of Oncology
[4] The Icelandic Cancer Registry,undefined
[5] Roche NimbleGen,undefined
[6] Inc.,undefined
来源：
Breast Cancer Research | / 13卷
关键词：
BRCA2 Mutation Carrier; BRCA2 Carrier; Sporadic Breast Cancer; Luminal Subtype; Familial Pancreatic Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 24 条
  • [1] Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression
    Stefansson, Olafur A.
    Jonasson, Jon G.
    Olafsdottir, Kristrun
    Bjarnason, Hordur
    Johannsson, Oskar Th
    Bodvarsdottir, Sigridur K.
    Valgeirsdottir, Sigridur
    Eyfjord, Jorunn E.
    BREAST CANCER RESEARCH, 2011, 13 (05):
  • [2] Co-occurring Genomic Alterations and Association With Progression-Free Survival in BRAFV600-Mutated Nonmelanoma Tumors
    Sen, Shiraj
    Meric-Bernstam, Funda
    Hong, David S.
    Hess, Kenneth R.
    Subbiah, Vivek
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (10):
  • [3] Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers
    Hamid, Abdulaziz B.
    Frank, Lauren E.
    Bouley, Renee A.
    Petreaca, Ruben C.
    PLOS ONE, 2022, 17 (09):
  • [4] Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
    Marieke A Vollebergh
    Esther H Lips
    Petra M Nederlof
    Lodewyk FA Wessels
    Jelle Wesseling
    Marc J vd Vijver
    Elisabeth GE de Vries
    Harm van Tinteren
    Jos Jonkers
    Michael Hauptmann
    Sjoerd Rodenhuis
    Sabine C Linn
    Breast Cancer Research, 16
  • [5] Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
    Vollebergh, Marieke A.
    Lips, Esther H.
    Nederlof, Petra M.
    Wessels, Lodewyk F. A.
    Wesseling, Jelle
    Vijver, Marc J. vd
    de Vries, Elisabeth G. E.
    van Tinteren, Harm
    Jonkers, Jos
    Hauptmann, Michael
    Rodenhuis, Sjoerd
    Linn, Sabine C.
    BREAST CANCER RESEARCH, 2014, 16 (03)
  • [6] Determination of tumoral genomic profiles not linked to BRCA1 and BRCA2 genes in a series of 101 familial cases of breast cancers
    Banneau, G.
    Guedj, M.
    Schiappa, R.
    Petel, F.
    Sevenet, N.
    Brouste, V
    De, Mascarel, I
    Longy, M.
    Bonner, F.
    BULLETIN DU CANCER, 2008, 95 : S43 - S43
  • [7] Co-occurring genomic alterations and association with progression free survival in BRAFV600 mutated non-melanoma tumors treated with BRAF inhibitor.
    Sen, Shiraj
    Rao, Arvind
    Janku, Filip
    Hong, David S.
    Tsimberidou, Apostolia Maria
    Piha-Paul, Sarina Anne
    Heymach, John
    Byers, Lauren Averett
    Meric-Bernstam, Funda
    Subbiah, Vivek
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Association of co-occurring gene alterations and clinical activity of rucaparib in patients with BRCA1 or BRCA2 mutated (BRCA plus ) metastatic castration-resistant prostate cancer (mCRPC)
    Abida, Wassim
    Patnaik, Akash
    Campbell, David
    Shapiro, Jeremy David
    Bryce, Alan Haruo
    McDermott, Raymond S.
    Sautois, Brieuc
    Vogelzang, Nicholas J.
    Bambury, Richard M.
    Voog, Eric
    Zhang Jingsong
    Piulats, Josep M.
    Ryan, Charles J.
    Merseburger, Axel Stuart
    Fizazi, Karim
    Despain, Darrin
    Loehr, Andrea
    Dowson, Melanie
    Golsorkhi, Tony
    Chowdhury, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [9] Genomic landscape analysis of ERBB3-mutated human cancers reveals common co-occurrence with activating ERBB2 alterations
    Odintsov, I.
    Somwar, R.
    Ladanyi, M.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S149 - S149
  • [10] Genomic Landscape Analysis of ERBB3-mutated Human Cancers Reveals Common Co-Occurrence with Activating ERBB2 Alterations
    Odintsov, Igor
    Somwar, Romel
    Ladanyi, Marc
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1255 - 1255
123